238 results on '"Frère, Corinne"'
Search Results
2. Traduction et republication de : « Événements thromboemboliques artériels liés au cancer »
3. Bleeding complications, coagulation disorders, and their management in acute myocardial infarction-related cardiogenic shock rescued by veno-arterial ECMO: A retrospective cohort study
4. Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group
5. Management of cancer-associated thromboembolism in vulnerable population
6. Management of venous thromboembolic disease in patients with malignant brain tumours
7. Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis
8. Maladie thromboembolique veineuse et cancer du sein
9. Treatment of cancer-associated venous thromboembolism: A focus on special populations
10. Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia
11. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis
12. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
13. A review of latest clinical practice guidelines for the management of cancer-associated thrombosis
14. Long-Term Cangrelor Administration in Neurology Intensive Care: A Case Series
15. GFHT proposals on the practical use of argatroban — With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)
16. Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
17. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports
18. Management of cancer-associated thromboembolism in vulnerable population
19. Management of venous thromboembolic disease in patients with malignant brain tumours
20. Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome
21. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
22. Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes
23. Comment gérer le risque d’interactions médicamenteuses ?
24. Traitement de la maladie thromboembolique veineuse chez les patients atteints de cancer : que faire en cas de thrombopénie ?
25. Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention
26. Tissue damage from neutrophil-induced oxidative stress in COVID-19
27. Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes
28. Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study
29. Anticorps antiphospholipides et hémodialyse : une association fréquente corrélée à la thrombose de l’abord vasculaire
30. Author Correction: Tissue damage from neutrophil-induced oxidative stress in COVID-19
31. A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential
32. Commentary on “Risk of venous thromboembolism after COVID‐19 vaccination”
33. Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention
34. FCGR2A-HH Gene Variants Encoding the Fc Gamma Receptor for the C-Reactive Protein Are Associated with Enhanced Monocyte CD32 Expression and Cardiovascular Events' Recurrence after Primary Acute Coronary Syndrome Accepted for publication in Biomedecines 19/02/22
35. Tissue factor–positive neutrophils bind to injured endothelial wall and initiate thrombus formation
36. Apport de la génomique des tumeurs dans la prédiction du risque de maladie thromboembolique veineuse chez les patients atteints de cancer : données émergentes et perspectives
37. Hormonothérapie et risque de maladie thromboembolique veineuse au cours du cancer du sein
38. Développement d’un site web ressource sur la maladie thromboembolique veineuse associée au cancer à l’usage des patients et des professionnels de santé
39. Traitement des maladies hématologiques et thromboses artérielles
40. Validation du score d’Ottawa dans la cohorte prospective TROPIQUE
41. Quand faut-il instaurer une thromboprophylaxie chez le patient atteint de cancer : indications et recommandations actuelles
42. Emicizumab does not interfere with the activated clotting time
43. Endothelial cell biomarkers in critically ill COVID‐19 patients with encephalitis
44. GFHT proposals on the practical use of argatroban — With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)
45. Clopidogrel response: Head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting
46. An epidemic of redundant meta‐analyses
47. Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.
48. Effect of increased aspirin dose after Stenting in association with ClOpidogrel: The FIASCO randomized study
49. Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response
50. Aspirin noncompliance is the major cause of “aspirin resistance” in patients undergoing coronary stenting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.